TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis.

Claudia Omarini,Federico Piacentini,Isabella Sperduti,Krisida Cerma,Monica Barbolini,Fabio Canino,Cecilia Nasso,Massimo Dominici,Luca Moscetti

TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis.

2021

Claudia Omarini
Federico Piacentini
Isabella Sperduti
Krisida Cerma
Monica Barbolini
Fabio Canino
Cecilia Nasso
Massimo Dominici
Luca Moscetti

e13010Background: Based on the results reported in Emilia trial population, current guidelines consider TDM-1 the standard second-line therapy for HER2 positive metastatic breast cancer (MBC) patie...

Keywords:

Internal medicine
Medicine
Meta-analysis
Oncology
Population
Trastuzumab
Metastatic breast cancer
Pertuzumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations